Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Semiconductors, Circuits & Optics
7 pending office actions • 3 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Medici Therapeutics Inc. currently manages 7 pending office actions within the Chemistry & Materials technology area. The distribution of these matters across 7 distinct examiners indicates a fragmented prosecution landscape where each examiner handles a separate case. This ratio between pending actions and examiners suggests that the company must navigate a variety of individual examiner styles simultaneously.
The portfolio is concentrated within 3 distinct art units, which provides some institutional consistency despite the number of examiners involved. BENJAMIN JOSEPH KASS is identified as the busiest examiner for this portfolio, though this individual is responsible for only 1 pending office action. This reinforces the observation that the workload is evenly spread across the 7 distinct examiners assigned to the company's active matters.
Practitioners should note that the presence of 7 pending office actions across 3 distinct art units requires a strategy that accounts for diverse technical perspectives within the Chemistry & Materials field. Because BENJAMIN JOSEPH KASS manages a limited workload of 1 pending office action, there is no central point of contact to consolidate examiner interviews across the broader portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 2 (29%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KASS, BENJAMIN JOSEPH | 1 | 32.6% | +58.9% |
| WITHERSPOON, SIKARL A | 1 | 86.2% | -20.1% |
| BORTOLI, JONATHAN | 1 | 76.3% | +41.2% |
| ALABI, OYELEYE A | 1 | 84.0% | +25.2% |
| MUI, CHRISTINE T | 1 | 78.3% | +19.9% |
| REVERMAN, CHAD ANDREW | 1 | 57.5% | +41.8% |
| KOMATSU, LI N | 1 | 59.8% | +71.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681538 | COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS | WITHERSPOON, SIKARL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18649451 | MICROFLUIDIC APPARATUS AND METHODS OF USE THEREOF | KASS, BENJAMIN JOSEPH | — |
| 18565192 | SYSTEMS AND METHODS TO DETECT PRESENCE OF FLUIDS | BORTOLI, JONATHAN | — |
| 18286851 | APPARATUS WITH DYNAMIC LIGHT SCATTERING ASSEMBLY | ALABI, OYELEYE A | — |
| 18276169 | MICROFLUIDIC CONCENTRATION AND BUFFER EXCHANGE APPARATUSES AND METHODS | MUI, CHRISTINE T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17615857 | LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID DELIVERY | KOMATSU, LI N | 55d |
| 18649451 | MICROFLUIDIC APPARATUS AND METHODS OF USE THEREOF | KASS, BENJAMIN JOSEPH | — |
| 18565192 | SYSTEMS AND METHODS TO DETECT PRESENCE OF FLUIDS | BORTOLI, JONATHAN | — |
| 18286851 | APPARATUS WITH DYNAMIC LIGHT SCATTERING ASSEMBLY | ALABI, OYELEYE A | — |
| 18276169 | MICROFLUIDIC CONCENTRATION AND BUFFER EXCHANGE APPARATUSES AND METHODS | MUI, CHRISTINE T | — |
| 17964185 | APPARATUS WITH DYNAMIC LIGHT SCATTERING ASSEMBLY | REVERMAN, CHAD ANDREW | — |
| Art Unit | Apps |
|---|---|
| 1797 | 2 |
| 2877 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18649451 | MICROFLUIDIC APPARATUS AND METHODS OF USE THEREOF | KASS, BENJAMIN JOSEPH | — | §102§103 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18681538 | COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS | WITHERSPOON, SIKARL A | — | §102DP | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18565192 | SYSTEMS AND METHODS TO DETECT PRESENCE OF FLUIDS | BORTOLI, JONATHAN | — | §101§102§103 | Non-Final OA | — | Pending | Nov 29, 2023 |
| 18286851 | APPARATUS WITH DYNAMIC LIGHT SCATTERING ASSEMBLY | ALABI, OYELEYE A | 1797 | §101§103 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18276169 | MICROFLUIDIC CONCENTRATION AND BUFFER EXCHANGE APPARATUSES AND METHODS | MUI, CHRISTINE T | 1797 | §103§112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 17964185 | APPARATUS WITH DYNAMIC LIGHT SCATTERING ASSEMBLY | REVERMAN, CHAD ANDREW | 2877 | §103 | Non-Final OA | — | Pending | Oct 12, 2022 |
| 17615857 | LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID DELIVERY | KOMATSU, LI N | 1658 | §103 | Final Rejection | 55d | Pending | Dec 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial